In this week’s edition of InnovationRx, we look at the Nobel Prize winners in medicine, Amgen’s direct-to-consumer effort, and more.
How The Shutdown Impacts Healthcare
In this week’s edition of InnovationRx, we look at the Nobel Prize winners in medicine, Amgen’s direct-to-consumer effort, and more.
www.forbes.com
October 8, 2025 at 4:30 PM
In this week’s edition of InnovationRx, we look at the Nobel Prize winners in medicine, Amgen’s direct-to-consumer effort, and more.
Amgen's lung cancer drug tarlatamab wins China approval reut.rs/4taQDz6
Amgen's lung cancer drug tarlatamab wins China approval
Amgen's lung cancer drug tarlatamab has won approval from China's National Medical Products Administration, its development and commercialisation partner BeOne Medicines said on Friday on WeChat.
reut.rs
April 10, 2026 at 1:50 PM
Amgen's lung cancer drug tarlatamab wins China approval reut.rs/4taQDz6
FDA proposes to withdraw Amgen's rare autoimmune disease drug reut.rs/4cD7ogt
FDA proposes to withdraw Amgen's rare autoimmune disease drug
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research on Monday proposed withdrawing approval of Amgen's drug for a group of rare autoimmune diseases, citing a lack of proven effectiveness and untrue statements in the application that led to its approval.
reut.rs
April 28, 2026 at 1:10 AM
FDA proposes to withdraw Amgen's rare autoimmune disease drug reut.rs/4cD7ogt
New favorite name for a drug (Amgen's):
Dazodalibep
Dazodalibep
September 22, 2026 at 1:05 PM
New favorite name for a drug (Amgen's):
Dazodalibep
Dazodalibep
US judge overturns Amgen's $50.3 mln loss in cancer drug patent case reut.rs/3UZytk2
US judge overturns Amgen's $50.3 mln loss in cancer drug patent case
Amgen convinced a federal judge in Delaware on Thursday to invalidate two patents owned by Lindis Biotech, undercutting a $50.3 million jury verdict Lindis won last year in an infringement lawsuit over Amgen's leukemia drug Blincyto.
reut.rs
August 14, 2025 at 7:45 PM
US judge overturns Amgen's $50.3 mln loss in cancer drug patent case reut.rs/3UZytk2
UK regulator suspends Amgen's Tavneos for new patients over unreliable data reut.rs/45V6PdL
UK regulator suspends Amgen's Tavneos for new patients over unreliable data
Britain's medicines regulator on Tuesday suspended the use and sale of Amgen's rare-disease drug, Tavneos, to new patients, saying the main study supporting its approval was unreliable.
reut.rs
September 1, 2026 at 12:01 PM
UK regulator suspends Amgen's Tavneos for new patients over unreliable data reut.rs/45V6PdL
Apply now to Amgen’s postbacc program!
April 9, 2026 at 5:41 PM
Apply now to Amgen’s postbacc program!
Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports reut.rs/4fqL2jP
Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports
About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with Amgen's rare disease drug Tavneos, according to a safety notice issued by partner Kissei Pharmaceutical on Friday.
reut.rs
May 16, 2026 at 12:30 AM
Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports reut.rs/4fqL2jP
Today, Trump posted on his Truth Social, lauding bio pharma giant Amgen’s billion-dollar expansion in North Carolina. Amgen proves #DEI, diversity, inclusion and belonging, equals success for #business.
Trump-Musk war on #DEI is a losing proposition.
@amgen.bsky.social #Amgen
Trump-Musk war on #DEI is a losing proposition.
@amgen.bsky.social #Amgen
December 25, 2024 at 6:47 PM
Today, Trump posted on his Truth Social, lauding bio pharma giant Amgen’s billion-dollar expansion in North Carolina. Amgen proves #DEI, diversity, inclusion and belonging, equals success for #business.
Trump-Musk war on #DEI is a losing proposition.
@amgen.bsky.social #Amgen
Trump-Musk war on #DEI is a losing proposition.
@amgen.bsky.social #Amgen
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings reut.rs/3RavFT1
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings
The New England Journal of Medicine on Monday retracted an article on a pivotal clinical trial that supported approval of Amgen’s rare-disease drug, citing concerns that patient outcome data were altered and that some researchers had been unblinded.
reut.rs
June 29, 2026 at 9:05 PM
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings reut.rs/3RavFT1
Global Health Dialogues with Princess Dina Mired: Amgen’s CMO Paul Burton
oncodaily.com/dialogues/32...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GlobalHealthDialogues
oncodaily.com/dialogues/32...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GlobalHealthDialogues
Global Health Dialogues with Princess Dina Mired: Amgen's CMO Paul Burton - OncoDaily
Global Health Dialogues with Princess Dina Mired: Amgen's CMO Paul Burton / cancer, Global Health Dialogues, OncoDaily, Oncology, Paul Burton, Princess Dina
oncodaily.com
July 11, 2025 at 8:50 PM
Global Health Dialogues with Princess Dina Mired: Amgen’s CMO Paul Burton
oncodaily.com/dialogues/32...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GlobalHealthDialogues
oncodaily.com/dialogues/32...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GlobalHealthDialogues
Amgen drug cuts small cell lung cancer death risk by 40% reut.rs/3HnWBJW
Amgen drug cuts small cell lung cancer death risk by 40%
Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease had worsened after an initial round of chemo, according to interim data from a late-stage trial presented at a major medical meeting on Monday.
reut.rs
June 2, 2025 at 12:10 PM
Amgen drug cuts small cell lung cancer death risk by 40% reut.rs/3HnWBJW
AstraZeneca's drug combo helps lung cancer patients live longer in late-stage study reut.rs/3UZ2PXe
AstraZeneca's drug combo helps lung cancer patients live longer in late-stage study
AstraZeneca said on Tuesday its cancer drug, Imfinzi, combined with Amgen's targeted immunotherapy, Imdelltra, significantly improved overall survival of extensive-stage small-cell lung cancer patients in a late-stage trial.
reut.rs
September 8, 2026 at 6:30 PM
AstraZeneca's drug combo helps lung cancer patients live longer in late-stage study reut.rs/3UZ2PXe
His cutting in line is not without precedent.
In October 2020, Trump refused intubation. So doctors put him on Amgen's hoarded, expensive mAbs cocktail and saved his life.
It may be the most self-defeating move of Big Pharma in a decade.
In October 2020, Trump refused intubation. So doctors put him on Amgen's hoarded, expensive mAbs cocktail and saved his life.
It may be the most self-defeating move of Big Pharma in a decade.
June 25, 2026 at 8:19 PM
His cutting in line is not without precedent.
In October 2020, Trump refused intubation. So doctors put him on Amgen's hoarded, expensive mAbs cocktail and saved his life.
It may be the most self-defeating move of Big Pharma in a decade.
In October 2020, Trump refused intubation. So doctors put him on Amgen's hoarded, expensive mAbs cocktail and saved his life.
It may be the most self-defeating move of Big Pharma in a decade.
Press Release: Amgen’s Bemarituzumab Shows Promise in Advanced Gastric Cancer
@amgen.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Amgen #Bemarituzumab #GastricCancer #GIOnc
@amgen.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Amgen #Bemarituzumab #GastricCancer #GIOnc
Amgen's Bemarituzumab Shows Promise in aGC:
Amgen announces positive FORTITUDE-101 trial results, showing bemarituzumab+chemotherapy improves OS in FGFR2b-positive aGC.
oncodaily.com
July 10, 2025 at 6:35 PM
Press Release: Amgen’s Bemarituzumab Shows Promise in Advanced Gastric Cancer
@amgen.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Amgen #Bemarituzumab #GastricCancer #GIOnc
@amgen.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Amgen #Bemarituzumab #GastricCancer #GIOnc
Amgen's Dazodalibep Hits Goal in Sjögren's Phase 3 Trial: Amgen's fusion protein dazodalibep showed statistically significant and clinically meaningful improvement in Sjögren's disease symptoms in a Phase 3 trial. The drug, inherited through Amgen's acquisition of… #MarketUpdates Follow Us for more
Amgen's Dazodalibep Hits Goal in Sjögren's Phase 3 Trial
Amgen's fusion protein dazodalibep showed statistically significant and clinically meaningful improvement in Sjögren's disease symptoms in a Phase 3 trial. The drug, inherited through Amgen's acquisition of Horizon Therapeutics, could become the first FDA-approved treatment for this autoimmune condition if a second pivotal trial also succeeds.
quantli.com
September 22, 2026 at 10:11 PM
Amgen's Dazodalibep Hits Goal in Sjögren's Phase 3 Trial: Amgen's fusion protein dazodalibep showed statistically significant and clinically meaningful improvement in Sjögren's disease symptoms in a Phase 3 trial. The drug, inherited through Amgen's acquisition of… #MarketUpdates Follow Us for more
Judge temporarily blocks Colorado’s first-in-the-nation price cap on a prescription drug
Judge temporarily blocks Colorado’s first-in-the-nation price cap on a prescription drug
A federal judge has temporarily blocked a price cap set by Colorado's Prescription Drug Affordability Board on Amgen's blockbuster drug Enbrel.
coloradosun.com
July 2, 2026 at 1:44 PM
Judge temporarily blocks Colorado’s first-in-the-nation price cap on a prescription drug
We are excited to be home to even more Amgen jobs here in North Carolina. They will bring in hundreds of new jobs, and their innovation will help bolster our economy. Let’s get to work, NC!
abc11.com/post/biotech...
abc11.com/post/biotech...
Biotech giant Amgen celebrates opening of new campus in Holly Springs
The celebration also included a ground-breaking for Amgen's next project, a second facility at the site.
abc11.com
January 28, 2025 at 1:03 AM
We are excited to be home to even more Amgen jobs here in North Carolina. They will bring in hundreds of new jobs, and their innovation will help bolster our economy. Let’s get to work, NC!
abc11.com/post/biotech...
abc11.com/post/biotech...
Amgen cholesterol drug cuts risk of first cardiac event by 25% reut.rs/3LCAtxj
Amgen cholesterol drug cuts risk of first cardiac event by 25%
Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25% for at-risk patients who have never had a heart attack or stroke, according to results from a large study presented on Saturday.
reut.rs
November 8, 2025 at 3:30 PM
Amgen cholesterol drug cuts risk of first cardiac event by 25% reut.rs/3LCAtxj
Anyone interested in working with me at Institute of Metabolic Science - Metabolic Research Laboratories, University of Cambridge, on how AMGEN's new obesity drug MariTide works? I have a 3 year postdoc position available! Deadline March 31st! please share www.jobs.cam.ac.uk/job/50529/
Research Associate (Fixed Term) - Job Opportunities - University of Cambridge
Research Associate (Fixed Term) in the Department of Clinical Biochemistry at the University of Cambridge.
www.jobs.cam.ac.uk
March 3, 2025 at 3:51 PM
Anyone interested in working with me at Institute of Metabolic Science - Metabolic Research Laboratories, University of Cambridge, on how AMGEN's new obesity drug MariTide works? I have a 3 year postdoc position available! Deadline March 31st! please share www.jobs.cam.ac.uk/job/50529/
EU regulator backs revoking Amgen's right to sell rare-disease drug reut.rs/4eFcbxC
EU regulator backs revoking Amgen's right to sell rare-disease drug
Europe's drug regulator on Friday recommended revoking the marketing authorization for Amgen's rare autoimmune disease medicine, citing concerns over the integrity of its trial data.
reut.rs
June 26, 2026 at 4:30 PM
EU regulator backs revoking Amgen's right to sell rare-disease drug reut.rs/4eFcbxC
#Amgen's anti-CD40L drug #dazodalibep has shown efficacy in a phase 3 trial in #Sjögrensdisease (SjD), raising hopes for a treatment that can alter the course of the debilitating #autoimmunedisorder.
pharmaphorum.com/news/amgens-...
pharmaphorum.com/news/amgens-...
Amgen's Horizon buyout delivers Sjögren's disease win
Amgen's anti-CD40L drug dazodalibep has shown efficacy in Sjögren's in a phase 3 trial, raising hopes for a disease-modifying drug for the disorder.
pharmaphorum.com
September 23, 2026 at 11:39 AM
#Amgen's anti-CD40L drug #dazodalibep has shown efficacy in a phase 3 trial in #Sjögrensdisease (SjD), raising hopes for a treatment that can alter the course of the debilitating #autoimmunedisorder.
pharmaphorum.com/news/amgens-...
pharmaphorum.com/news/amgens-...
September 22, 2026 at 3:00 AM
Amgen's lung cancer drug tarlatamab has won approval from China's National Medical Products Administration, its development and commercialisation partner BeOne Medicines said on Friday on WeChat.
Amgen's lung cancer drug tarlatamab wins China approval
Amgen's lung cancer drug tarlatamab has won approval from China's National Medical Products Administration, its development and commercialisation partner BeOne Medicines said on Friday on WeChat.
reut.rs
April 10, 2026 at 8:15 AM
Amgen's lung cancer drug tarlatamab has won approval from China's National Medical Products Administration, its development and commercialisation partner BeOne Medicines said on Friday on WeChat.